BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18755987)

  • 21. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats.
    Takagi T; Naito Y; Ichikawa H; Tomatsuri N; Katada K; Isozaki Y; Kuroda M; Kokura S; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):376-81. PubMed ID: 15720836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY; Kim HS
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
    Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
    Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells.
    Jung WK; Lee CM; Lee DS; Na G; Lee DY; Choi I; Park SG; Seo SK; Yang JW; Choi JS; Lee YM; Park WS; Choi IW
    Int J Mol Med; 2014 Feb; 33(2):449-56. PubMed ID: 24337644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells.
    Lin YC; Huang GD; Hsieh CW; Wung BS
    Free Radic Biol Med; 2012 May; 52(9):1844-53. PubMed ID: 22387200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
    Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
    J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
    Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
    Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice.
    Han Z; Zhu T; Liu X; Li C; Yue S; Liu X; Yang L; Yang L; Li L
    Hepatology; 2012 Jul; 56(1):350-60. PubMed ID: 22371273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress.
    Jozkowicz A; Was H; Taha H; Kotlinowski J; Mleczko K; Cisowski J; Weigel G; Dulak J
    Antioxid Redox Signal; 2008 Dec; 10(12):2035-46. PubMed ID: 18665800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells.
    Wung BS; Wu CC; Hsu MC; Hsieh CW
    Life Sci; 2006 May; 78(26):3035-42. PubMed ID: 16413037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway.
    Napimoga MH; Vieira SM; Dal-Secco D; Freitas A; Souto FO; Mestriner FL; Alves-Filho JC; Grespan R; Kawai T; Ferreira SH; Cunha FQ
    J Immunol; 2008 Jan; 180(1):609-17. PubMed ID: 18097063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
    J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells.
    Wang Y; Tan H; Xu D; Ma A; Zhang L; Sun J; Yang Z; Liu Y; Shi G
    Int J Mol Med; 2014 Jul; 34(1):262-8. PubMed ID: 24820432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-Deoxy-Δ
    Takagi T; Naito Y; Mizushima K; Hirai Y; Kamada K; Uchiyama K; Handa O; Ishikawa T; Itoh Y
    Arch Biochem Biophys; 2019 Nov; 677():108183. PubMed ID: 31704099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.